Shanghai Ming Ju Biotechnology Co., Ltd. Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2019
NCT04089215
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai Ming Ju Biotechnology Co., Ltd.